IFNB1 and infection: When administered 24 hours post-infection, many of the two-drug combinations showed strong synergism in inhibiting trVLP replication (Fig 4J), with IFN-β + 3TC demonstrating the greatest synergism (97.3% inhibition, CI = 0.028).